Off-label GLP-1 use highlights the cultural pressures driving body anxieties
A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as…
Hansal Mehta questions why ozempic & mounjaro have become ‘bad words’: “It’s helping millions live healthier” |
Filmmaker Hansal Mehta has spoken out about the growing stigma around modern medications used to treat metabolic disorders…
Gut probiotic Christensenella tenuis reduces endotoxemia and improves metabolism in obese mice
This study is reported by the team of Professor Shuang-jiang Liu from Shandong University. The study reveals that…
Menopause found to shape initial symptoms and comorbidities in multiple sclerosis
New research presented today at the 41st Congress of the European Committee for Treatment and Research in Multiple…
Coffee protects the liver by blocking inflammation and scarring, review finds
Scientists reveal how your daily cup of coffee may guard against liver disease, connecting population trends with the…
Scientists Solve Medical Mystery Behind Rare Multi-Organ Disease
Scientists have uncovered the genetic cause of a mysterious multi-organ disease, tracing it to faulty versions of the…
High fat diet impairs memory formation through autophagy dysfunction
Modern lifestyles and dietary changes have significantly increased the consumption of high-fat foods, contributing to a steep rise…
Female-specific mechanism enhances heat production in brown fat
Higher activity of PGC-1α enables brown fat cells in females to thermogenic activity and energy expenditure compared to…
WHO adds GLP-1RAs to essential medicines list
The World Health Organisation (WHO) has added key obesity and type 2 diabetes (T2D) medications semaglutide, tirzepatide, liraglutide…
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target
Schlame, M. & Xu, Y. The function of tafazzin, a mitochondrial phospholipid-lysophospholipid acyltransferase. J. Mol. Biol. 432, 5043–5051…